Publications
- Grellier P., Sabbah M., Fouqueray B., Woodruff K., Yee D., Abboud HA. and Abboud SL. Characterization of insulin-like growth factor binding proteins (IGFBP) and regulation of IGFBP-3 in glomerular mesangial cells. Kidney Int. 1996 ; 49 : 1071-1078.
- Grellier P., Chanson P., Casadevall N., Abboud SL. and Schaison G. Remission of polycythemia vera after surgical cure of acromegaly. Ann. Int. Med. 1996 ; 124 : 495-496.
- Grellier P., de Galle B. and Babajko S. Expression of insulin-like growth factor binding protein-6 complementary DNA alters neuroblastoma cell growth. Cancer Res. 1998 ; 58 : 1670-1676.
- Bienvenu G., Seurin D., Grellier P., Baudrimont M., Monget P., Le Bouc Y. and Babajko S. Insulin-like Growth Factor Binding Protein-6 transgenic mice : post-natal growth, brain development and reproduction abnormalities. Endocrinology. 2004 ; 145(5) : 2412-2420.
- Bolze S, Bromet N, Gay-Feutry C, Massiere F, Boulieu R, Hulot T. Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin. Drug Metab Dispos. 2002 Apr;30(4):404-13
- Fossati L, Dechaume R, Hardillier E, Chevillon D, Prevost C, Bolze S and Maubon N. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs. Int J Pharm. 2008 Aug 6;360(1-2):148-55. Epub 2008 Apr 29
- Maubon N, Le Vee M, Fossati L, Audry M, Le Ferrec E, Bolze S, Fardel O. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam Clin Pharmacol. 2007 Dec;21(6):659-63.
- Hallakou S., Doaré L., Foufelle F., Kergoat M., Guerre-Millo M., Berthault MF., Dugail I., Morin J., Auwerx J., Ferré P. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat Diabetes 1997, 46: 1393-9
- Hallakou S., Foufelle F., Doaré L., Kergoat M., and Ferré P. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat explained by local adipocyte differentiation. Diabetologia 1998; 41: 963-8
- Lo KM., Zhang J., Sun Y., Morelli B., Lan Y., Lauder S., Brunkhorst B., Webster G., Hallakou-Bozec S., Doaré L. and Gillies SD. Engineering a pharmacologically superior form of leptin for the treatment of obesity. Protein Eng. Des. Sel. 2005, 18: 1-10
- H. HOWLETT, F. PORTE, T. ALLAVOINE, T. KUHN and G. NICHOLSON. The development of an oral antidiabetic tablet: design, evaluation and clinical benefits for patients with type 2 diabetes. Current medical research and Opinion 2003, 19 (3) : 218-225
